Search results
Aug 23, 2012 · Loren D Walensky is an Associate Professor of Pediatrics at Harvard Medical School, faculty member in the Department of Pediatric Hematology/Oncology at Dana-Farber Cancer Institute/Children’s Hospital Boston, and Medical Director of Dana-Farber’s Program in Cancer Chemical Biology. He graduated as valedictorian from Princeton University in ...
486. 2010. The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members. GL Verdine, LD Walensky. Clinical cancer research 13 (24), 7264-7270. , 2007. 475. 2007. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.
People also ask
Who is Loren Walensky?
What does the Walensky laboratory do?
Where did Dr Walensky go to medical school?
Loren David Walensky. Professor of Pediatrics. The Walensky laboratory focuses on the chemical biology of deregulated apoptotic and transcriptional pathways in cancer. Our goal is to develop an arsenal of new compounds-a “chemical toolbox”-to investigate and block protein interactions that cause cancer. To achieve these objectives, we take ...
Proto-Oncogene Proteins c-bcl-2. Small Molecule Libraries. Loren D Walensky is an Associate Professor of Pediatrics at Harvard Medical School, faculty member in the Department of Pediatric Hematology/Oncology at Dana-Farber Cancer Institute/Children's Hospital Boston, and Medical Director of Dana-Farber's Program in Cancer Chemical Biology.
- Loren D Walensky
- 2012
Loren D. Walensky. Loren David Walensky is an American physician-scientist and pediatric oncologist at the Dana–Farber Cancer Institute since 2003 and a professor of pediatrics at the Dana–Farber/Harvard Cancer Center. He researches peptides and oncogenic pathways. In 2013, Walensky became director of the joint MD/PhD program at Harvard ...
- 3
- .mw-parser-output .marriage-line-margin2px{line-height:0;margin-bottom:-2px}.mw-parser-output .marriage-line-margin3px{line-height:0;margin-bottom:-3px}.mw-parser-output .marriage-display-ws{display:inline;white-space:nowrap}, Rochelle Walensky (m. 1995)
Aug 19, 2019 · Walensky, L. D. et al. Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science 305 , 1466–1470 (2004). Article CAS Google Scholar
Aug 1, 2012 · Loren D Walensky is an Associate Professor of Pediatrics at Harvard Medical School, faculty member in the Department of Pediatric Hematology/Oncology at Dana-Farber Cancer Institute/Children's ...
